NASDAQ:NCNANuCana Competitors & Alternatives Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding NuCana PLC Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $6.34 +0.17 (+2.76 %) (As of 06/5/2020 04:00 PM ET) Add Compare Share Today's Range$6.08Now: $6.34▼$6.3850-Day Range$5.35MA: $5.80▼$7.3752-Week Range$3.81Now: $6.34▼$12.79Volume97,117 shsAverage Volume124,184 shsMarket Capitalization$205.92 millionP/E RatioN/ADividend YieldN/ABeta1.11 ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsSocial Media Competitors NuCana (NASDAQ:NCNA) Competitors and AlternativesThe following companies in the "pharmaceutical preparations" industry are considered alternatives and competitors to NuCana.Competitor NameBeat the Market RankCurrent PricePrice ChangeMarket CapRevenueP/E RatioIndicator(s)GOSSGossamer Bio1.4$12.49+0.6%$838.77 millionN/A-3.78CUECue Biopharma1.0$24.44+9.8%$815.37 million$3.46 million-15.09IMGNImmunoGen1.4$4.55+0.9%$810.13 million$82.27 million-7.84OMEROmeros1.5$14.42+3.7%$786.03 million$111.81 million-8.34IMRAPassage Bio1.9$47.12+10.9%$775.89 millionN/A0.00Analyst UpgradeNBRVNabriva Therapeutics1.5$0.79+0.0%$766.45 million$9.48 million-0.73High Trading VolumeAnalyst RevisionCARACara Therapeutics1.5$15.37+1.6%$747.69 million$19.89 million-6.03KURAKura Oncology1.6$16.24+0.9%$744.71 millionN/A-10.48Analyst RevisionNXTCNextCure1.6$25.46+2.8%$739.67 million$6.35 million-25.72Analyst DowngradeHigh Trading VolumeKALAKala Pharmaceuticals2.3$13.59+1.7%$738.34 million$6.07 million-5.33Analyst ReportMTEMMolecular Templates1.6$14.22+5.1%$733.61 million$22.27 million-6.55MORFMorphic1.6$23.23+2.8%$730.80 million$16.98 million-3.72Analyst DowngradeRTRXRetrophin1.3$15.79+6.0%$722.42 million$175.34 million-6.44ARCTArcturus Therapeutics0.9$32.66+2.8%$718.31 million$20.79 million-15.85FIXXHomology Medicines1.7$15.75+0.3%$714.32 million$1.67 million-6.03COLLCollegium Pharmaceutical1.8$19.68+0.8%$701.91 million$296.70 million-51.79Insider SellingKDMNKadmon2.1$4.48+2.5%$699.33 million$5.09 million-6.40Analyst DowngradePRVBProvention Bio1.9$12.19+21.3%$691.35 millionN/A-11.72Analyst ReportHigh Trading VolumeUnusual Options ActivityHeavy News ReportingGTHXG1 Therapeutics1.4$19.87+8.1%$689.51 millionN/A-5.78High Trading VolumeEGRXEagle Pharmaceuticals1.0$49.48+3.4%$681.08 million$195.89 million291.08KROSPassage Bio1.4$31.83+1.2%$660.87 millionN/A0.00ZIOPZIOPHARM Oncology1.4$3.11+1.9%$653.58 million$150,000.00-4.44AKROAkero Therapeutics1.4$24.05+1.3%$653.19 millionN/A-6.43SVASinovac Biotech0.6$6.47+0.0%$639.90 million$246.05 million17.03High Trading VolumeASMBAssembly Biosciences1.3$22.00+9.3%$638.41 million$15.96 million-6.41Analyst DowngradeVNDAVanda Pharmaceuticals2.0$11.46+0.2%$638.24 million$227.19 million5.36STMLStemline Therapeutics1.4$11.92+0.1%$638.01 million$43.22 million-7.50Analyst ReportARDXArdelyx1.6$6.92+0.1%$622.06 million$5.28 million-5.28Analyst DowngradeInsider SellingSNDXSyndax Pharmaceuticals1.6$16.89+0.7%$605.76 million$1.52 million-8.98DVAXDynavax Technologies2.1$6.09+6.4%$597.33 million$35.22 million-3.31Analyst UpgradeTRILTrillium Therapeutics1.6$7.15+2.8%$596.60 million$120,000.00-3.56Heavy News ReportingRDUSRadius Health1.9$12.25+2.7%$583.57 million$173.32 million-4.42Analyst DowngradeFREQFrequency Therapeutics1.5$18.82+1.9%$572.50 million$28.95 million-8.22Insider SellingAPREAprea Therapeutics1.3$26.94+1.4%$559.22 millionN/A-5.77ATHXAthersys1.4$2.78+1.8%$556.04 million$5.63 million-9.27URGNUrogen Pharma1.6$26.58+1.5%$555.52 million$20,000.00-4.59ZFGNZafgen0.9$14.70+8.8%$550.81 millionN/A-15.31ANABAnaptysBio1.2$18.67+2.0%$536.87 million$8 million-6.04CRNXCrinetics Pharmaceuticals1.4$15.99+3.3%$526.91 million$1.19 million-6.61Analyst DowngradeBCELAtreca1.6$18.34+0.5%$517.12 millionN/A-3.22Analyst DowngradeInsider SellingVKTXViking Therapeutics1.8$7.38+3.4%$516.16 millionN/A-17.57Analyst ReportHeavy News ReportingCRBPCorbus Pharmaceuticals2.2$6.89+0.0%$508.30 million$36.14 million-6.10Analyst DowngradeUnusual Options ActivityHeavy News ReportingCLVSClovis Oncology1.7$6.68+3.0%$498.31 million$143.01 million-0.93BDSIBioDelivery Sciences International1.9$4.81+1.5%$482.52 million$111.39 million-53.44DRRXDURECT1.6$2.41+5.8%$480.26 million$29.56 million-20.08Insider SellingBYSIBeyondspring1.3$17.29+1.5%$474.89 millionN/A-11.30NLTXNeoleukin Therapeutics1.8$12.20+0.1%$468.11 million$25 million-4.57FULCFulcrum Therapeutics1.4$19.04+5.5%$466.53 millionN/A-1.63VBIVVBI Vaccines2.1$2.00+5.0%$465.91 million$2.22 million-5.71FLXNFlexion Therapeutics2.4$12.30+3.4%$463.11 million$72.96 million-3.25Analyst Report This page was last updated on 6/5/2020 by MarketBeat.com Staff
